In addition, there is cross-lineage expression of markers, including CD5, CD22 and CD18, on leukemic cells in ALL and AML (2, 3, 16), which can confound determination of the involved lineage in an acute leukemia. This evidence concerns the gene ITGB2 and acute myeloid leukemia.